Login to Your Account



OrbiMed $600M Royalty Fund Opens for Business

By Catherine Shaffer


Thursday, September 1, 2011
OrbiMed Advisors LLC has closed a new fund dedicated to acquiring health care royalty streams and providing minimally dilutive debt capital to companies in the health care sector. The $600 million fund will provide an alternative to financing through the equity markets for companies with approved products or products close to approval. The fund has already made two investments: XOMA Ltd. and Velico Medical Inc.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription